Quest Diagnostics Launches COVID-19 Workforce Testing Services to Help Guide Organizations in Fostering Safer Workplaces as Employees Return to Work

COVID-19 molecular diagnostic and serology antibody testing at core of new suite of services

Quest Diagnostics, the world’s leading provider of diagnostic information services, launched a new suite of Return to Work services built around large-scale workforce COVID-19 testing. The services are designed to help organizations access and act on COVID-19 laboratory insights in order to foster safer workplace environments for their employees as the nation begins to restart the U.S. economy.

HR Technology News: TecHRseries Interview with Saray Ben-Meir, Chief of Staff at SQream

The Quest Diagnostics Return to Work services feature access to COVID-19 diagnostic and antibody testing and related capabilities, from event staffing to digital results reporting. For more information, visit www.QuestforHealth.com.

HR Technology News: TecHRseries Interview with Carlo Fidanza, Chief People Officer at Accedian

“All of us are eager to get back to work as safely as possible, and COVID-19 testing is essential to making this happen,” said Steve Rusckowski, Chairman, CEO and President, Quest Diagnostics. “Quest has been at the forefront of COVID-19 testing, and our Return to Work solution is informed by this experience as well as our leadership in population health services for employers across the country. Given our relationships with thousands of employers, we feel Quest can make a major contribution with our Return to Work services. We will empower organizations of all sizes to use lab insights to help them foster safer and healthy environments as our nation plans to reopen our economy.”

COVID-19 laboratory testing principally involves molecular diagnostics to detect viral RNA during active disease and serology testing to identify antibodies produced by the body following exposure to the virus. Both types of tests provide insights into disease risk for individuals and populations. Quest is committed to high quality COVID-19 testing and analysis and uses tests that have received FDA emergency use authorization as well as met the company’s rigorous quality criteria.

Quest Diagnostics is the leading provider of employee population health and workplace drug testing services, serving thousands of employers across the United States. The company’s services range from lab and biometric screening to behavioral and mental health interventions to telemedicine and flu clinics.

HR Technology News: RizePoint User, Regency, Experiences Huge Benefits from RizePoint Solutions: Tools Elevate Protocols, Demonstrate Safety Compliance, Help Employees & Customers Feel Safe in New Post-COVID World

Write into psen@itechseries.com to learn more about our exclusive editorial packages and programs.

COVID-19economyHR TechnologyNEWSQuest DiagnosticsQuestforHealthReturn to Work
Comments (0)
Add Comment